Kinge, Jonas Minet
Øien, Henning
Dieleman, Joseph L.
Reme, Bjørn-Atle
Knudsen, Ann Kristin Skrindo
Godager, Geir
Selbæk, Geir
Frich, Jan C.
Barış, Enis
Murray, Christopher J. L.
Vollset, Stein Emil
Funding for this research was provided by:
Norwegian Institute of Public Health
Article History
Received: 22 November 2024
Accepted: 30 January 2025
First Online: 25 February 2025
Declarations
:
: The microdata used for the Norwegian Health Spending Project was approved, and participant consent was waived, by the Regional Committee for Medical and Health Research Ethics South-East Norway, reference number 184544.
: Not applicable.
: GS has received honoraria for giving lectures at symposia sponsored by Eisai and Eli-Lilly. GS had participated at advisory boards for Eisai and Eli-Lilly concerning anti-amyloid treatment in Alzheimer’s disease.